Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBC
926
DELISTED
WABCO HOLDINGS INC.
WBC
| $13.5M | 0.03% |
126,000
-164,900
| -57% | -$15.6M |
|
927
Sumitomo Mitsui Financial
SMFG
$167B
| $13.4M | 0.03% |
2,235,600
+833,200
| +59% | +$5.2M |
|
928
Anika Therapeutics
ANIK
$295M
| $13.4M | 0.03% |
300,400
+187,400
| +166% | +$7.6M |
|
929
Alnylam Pharmaceuticals
ALNY
$30.4B
| $13.4M | 0.03% |
+214,000
| New | +$14.2M |
|
|
DRII
930
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $13.4M | 0.03% |
552,600
+182,000
| +49% | +$3.89M |
|
931
Ameris Bancorp
ABCB
$6B
| $13.4M | 0.03% |
453,183
-4,717
| -1% | -$134K |
|
|
SIGM
932
DELISTED
Sigma Designs Inc
SIGM
| $13.4M | 0.03% |
1,965,400
+64,100
| +3% | +$423K |
|
|
SWC
933
DELISTED
Stillwater Mining Co
SWC
| $13.3M | 0.03% |
1,252,700
+166,000
| +15% | +$1.33M |
|
|
MFA
934
MFA Financial
MFA
$925M
| $13.3M | 0.03% |
486,475
+287,525
| +145% | +$7.54M |
|
935
MarketAxess Holdings
MKTX
$5.72B
| $13.3M | 0.03% |
106,700
-82,610
| -44% | -$9.43M |
|
|
FSP
936
Franklin Street Properties
FSP
$46.3M
| $13.3M | 0.03% |
1,254,200
+223,000
| +22% | +$2.17M |
|
937
Lesaka Technologies
LSAK
$408M
| $13.3M | 0.03% |
1,440,500
+338,900
| +31% | +$3.42M |
|
938
TE Connectivity
TEL
$62B
| $13.2M | 0.03% |
213,900
+153,400
| +254% | +$8.91M |
|
|
LUMO
939
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $13.2M | 0.03% |
80,744
+74,419
| +1,177% | +$15.1M |
|
|
FARM
940
DELISTED
Farmer Brothers
FARM
| $13.2M | 0.03% |
474,500
+12,700
| +3% | +$340K |
|
|
CLR
941
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $13.2M | 0.03% |
435,300
-537,300
| -55% | -$12.1M |
|
942
Cooper-Standard Automotive
CPS
$490M
| $13.2M | 0.03% |
183,600
+81,946
| +81% | +$5.82M |
|
943
Tractor Supply
TSCO
$18.8B
| $13.2M | 0.03% |
727,500
-826,000
| -53% | -$14.1M |
|
944
Mesa Laboratories
MLAB
$631M
| $13.1M | 0.03% |
136,400
-2,199
| -2% | -$198K |
|
945
SPX Corp
SPXC
$10.9B
| $13.1M | 0.02% |
870,500
+80,700
| +10% | +$862K |
|
|
WCN
946
Waste Connections
WCN
$41.6B
| $13.1M | 0.02% |
303,207
+155,307
| +105% | +$6.26M |
|
|
TWTR
947
DELISTED
Twitter, Inc.
TWTR
| $13.1M | 0.02% |
+788,900
| New | +$13.8M |
|
|
AUO
948
DELISTED
AU Optronics Corp
AUO
| $13.1M | 0.02% |
4,425,184
+481,984
| +12% | +$1.31M |
|
949
Camden Property Trust
CPT
$10.9B
| $13M | 0.02% |
155,000
+115,900
| +296% | +$8.85M |
|
950
Aaon
AAON
$7.23B
| $13M | 0.02% |
696,413
+36,515
| +6% | +$559K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.